Cargando...
Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss
Multiple myeloma (MM) is a plasma cell malignancy, characterized by osteolytic lesions and monoclonal immunoglobulins. The anemia, accompanying the disease is often treated with recombinant human EPO. Diverse non-erythropoietic effects of EPO have led us to question its combined action on the immune...
Guardado en:
| Publicado en: | Sci Rep |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4969594/ https://ncbi.nlm.nih.gov/pubmed/27481313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep30998 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|